This HTML5 document contains 63 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n17http://linked.opendata.cz/resource/domain/vavai/subjekt/
n16http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
n11http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00023736%3A_____%2F11%3A00008834%21RIV12-MZ0-00023736/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00023736%3A_____%2F11%3A00008834%21RIV12-MZ0-00023736
rdf:type
skos:Concept n16:Vysledek
rdfs:seeAlso
http://dx.doi.org/10.1002/ajh.21942
dcterms:description
We analyzed efficacy and safety of imatinib in the first line therapy of 152 consecutive adult patients with chronic myeloid leukemia diagnosed in chronic phase from a defined region. We confirmed very good efficacy and safety of imatinib also in non-study patients treated in experienced centers. More appropriate selection of end-points in survival analyses is desirable to describe the real efficacy of imatinib and other TKIs. We analyzed efficacy and safety of imatinib in the first line therapy of 152 consecutive adult patients with chronic myeloid leukemia diagnosed in chronic phase from a defined region. We confirmed very good efficacy and safety of imatinib also in non-study patients treated in experienced centers. More appropriate selection of end-points in survival analyses is desirable to describe the real efficacy of imatinib and other TKIs.
dcterms:title
Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials? Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?
skos:prefLabel
Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials? Imatinib as the first line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: can we compare real life data to the results from clinical trials?
skos:notation
RIV/00023736:_____/11:00008834!RIV12-MZ0-00023736
n16:predkladatel
n17:ico%3A00023736
n4:aktivita
n5:V n5:I
n4:aktivity
I, V
n4:cisloPeriodika
3
n4:dodaniDat
n9:2012
n4:domaciTvurceVysledku
n6:7529805 n6:7163045 n6:6881203 n6:1459368 n6:8103054 n6:6663745 n6:7848226
n4:druhVysledku
n18:J
n4:duvernostUdaju
n19:S
n4:entitaPredkladatele
n13:predkladatel
n4:idSjednocenehoVysledku
203573
n4:idVysledku
RIV/00023736:_____/11:00008834
n4:jazykVysledku
n12:eng
n4:klicovaSlova
chronic myeloid leukemia; chronic phase; Imatinib
n4:klicoveSlovo
n8:chronic%20phase n8:chronic%20myeloid%20leukemia n8:Imatinib
n4:kodStatuVydavatele
US - Spojené státy americké
n4:kontrolniKodProRIV
[F48CBE764469]
n4:nazevZdroje
American Journal of Hematology
n4:obor
n10:FD
n4:pocetDomacichTvurcuVysledku
7
n4:pocetTvurcuVysledku
18
n4:rokUplatneniVysledku
n9:2011
n4:svazekPeriodika
86
n4:tvurceVysledku
Cetkovský, Petr Mužík, J. Březinová, Jana Dvořáková, D. Dušek, L. Rázga, F. Moravcová, Jana Michalová, Kyra Ráčil, Z. Pospíšil, Z. Mayer, J. Trněný, Marek Machová Poláková, Kateřina Žáčková, D. Klamová, Hana Jurček, T. Oltová, A. Doubek, M.
n4:wos
000287670600017
s:issn
0361-8609
s:numberOfPages
4
n11:doi
10.1002/ajh.21942